Topical Gentamicin for the Treatment of Genetic Skin Diseases

Anna M. G. Pasmooij*

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

5 Citations (Scopus)

Abstract

Clinical application of topical gentamicin is a worthwhile option to investigate further for Nagashima-type palmoplantar keratosis and other genetic skin diseases caused by nonsense mutations. It is especially interesting to study gentamicin 1B because it may be more efficacious than other gentamicin components. Topical gentamicin has an acceptable safety profile, although prospective tracking of antibiotic resistance is warranted.

Original languageEnglish
Pages (from-to)731-734
Number of pages4
JournalJournal of Investigative Dermatology
Volume138
Issue number4
DOIs
Publication statusPublished - Apr-2018

Keywords

  • PALMOPLANTAR KERATOSIS
  • AMINOGLYCOSIDES
  • SERPINB7
  • NONSENSE

Cite this